In conclusion, we have identified miR-126 as a regulator of stem cell-related gene Sox9 expression and SOX9+ LPCs properties in liver repair by targeting Hoxb6. Our principal findings may have a clinical implication for treating liver diseases. This evidence concerns the gene HOXB6 and liver disorder.